Abbood H, Hijazi K, Gould I
Antibiotics (Basel). 2023; 12(5).
PMID: 37237701
PMC: 10215778.
DOI: 10.3390/antibiotics12050798.
Caruso C, Eletto D, Tosco A, Pannetta M, Scarinci F, Troisi M
Microorganisms. 2022; 10(6).
PMID: 35744674
PMC: 9229167.
DOI: 10.3390/microorganisms10061156.
Chug M, Massoumi H, Wu Y, Brisbois E
J Biomed Mater Res A. 2022; 110(6):1263-1277.
PMID: 35170212
PMC: 8986591.
DOI: 10.1002/jbm.a.37372.
Liu X, Omar M, Nagaraja K, Goyal S, Vidovic S
Int J Mol Sci. 2021; 22(16).
PMID: 34445643
PMC: 8396259.
DOI: 10.3390/ijms22168938.
Muehler D, Rupp C, Keceli S, Brochhausen C, Siegmund H, Maisch T
Front Microbiol. 2020; 11:589364.
PMID: 33193252
PMC: 7662152.
DOI: 10.3389/fmicb.2020.589364.
A Novel Vitamin E TPGS-Based Formulation Enhances Chlorhexidine Bioavailability in Corneal Layers.
Caruso C, Porta A, Tosco A, Eletto D, Pacente L, Bartollino S
Pharmaceutics. 2020; 12(7).
PMID: 32650410
PMC: 7407793.
DOI: 10.3390/pharmaceutics12070642.
Short- and Long-Term Transcriptomic Responses of Escherichia coli to Biocides: a Systems Analysis.
Merchel Piovesan Pereira B, Wang X, Tagkopoulos I
Appl Environ Microbiol. 2020; 86(14).
PMID: 32385082
PMC: 7357472.
DOI: 10.1128/AEM.00708-20.
Resistance Toward Chlorhexidine in Oral Bacteria - Is There Cause for Concern?.
Cieplik F, Jakubovics N, Buchalla W, Maisch T, Hellwig E, Al-Ahmad A
Front Microbiol. 2019; 10:587.
PMID: 30967854
PMC: 6439480.
DOI: 10.3389/fmicb.2019.00587.
Resistance of Bacteria to Biocides.
Maillard J
Microbiol Spectr. 2018; 6(2).
PMID: 29676244
PMC: 11633572.
DOI: 10.1128/microbiolspec.ARBA-0006-2017.
Synthesis and antimicrobial activity of chiral quaternary -spiro ammonium bromides with 3',4'-dihydro-1'H-spiro[isoindoline-2,2'-isoquinoline] skeleton.
Bielawski K, Leszczynska K, Kaluza Z, Bielawska A, Michalak O, Daniluk T
Drug Des Devel Ther. 2017; 11:2015-2028.
PMID: 28740363
PMC: 5503491.
DOI: 10.2147/DDDT.S133250.
Formulation of Biocides Increases Antimicrobial Potency and Mitigates the Enrichment of Nonsusceptible Bacteria in Multispecies Biofilms.
Forbes S, Cowley N, Humphreys G, Mistry H, Amezquita A, McBain A
Appl Environ Microbiol. 2017; 83(7).
PMID: 28115386
PMC: 5359493.
DOI: 10.1128/AEM.03054-16.
Proteomic Analyses of Chlorhexidine Tolerance Mechanisms in Delftia acidovorans Biofilms.
Rema T, Medihala P, Lawrence J, Vidovic S, Leppard G, Reid M
mSphere. 2016; 1(1).
PMID: 27303691
PMC: 4863599.
DOI: 10.1128/mSphere.00017-15.
Microbicides Alter the Expression and Function of RND-Type Efflux Pump AdeABC in Biofilm-Associated Cells of Acinetobacter baumannii Clinical Isolates.
Krishnamoorthy S, Shah B, Lee H, Martinez L
Antimicrob Agents Chemother. 2015; 60(1):57-63.
PMID: 26459900
PMC: 4704159.
DOI: 10.1128/AAC.01045-15.
Transient and sustained bacterial adaptation following repeated sublethal exposure to microbicides and a novel human antimicrobial peptide.
Forbes S, Dobson C, Humphreys G, McBain A
Antimicrob Agents Chemother. 2014; 58(10):5809-17.
PMID: 25049246
PMC: 4187928.
DOI: 10.1128/AAC.03364-14.
Microscopic and spectroscopic analyses of chlorhexidine tolerance in Delftia acidovorans biofilms.
Rema T, Lawrence J, Dynes J, Hitchcock A, Korber D
Antimicrob Agents Chemother. 2014; 58(10):5673-86.
PMID: 25022584
PMC: 4187954.
DOI: 10.1128/AAC.02984-14.
Transcriptomic and biochemical analyses identify a family of chlorhexidine efflux proteins.
Hassan K, Jackson S, Penesyan A, Patching S, Tetu S, Eijkelkamp B
Proc Natl Acad Sci U S A. 2013; 110(50):20254-9.
PMID: 24277845
PMC: 3864336.
DOI: 10.1073/pnas.1317052110.
Potassium loss from chlorhexidine-treated bacterial pathogens is time- and concentration-dependent and variable between species.
ODriscoll N, Labovitiadi O, Cushnie T, Matthews K, Lamb A
Curr Microbiol. 2013; 68(1):6-11.
PMID: 23928905
DOI: 10.1007/s00284-013-0433-3.
Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli.
Cheung H, Wong M, Cheung S, Liang L, Lam Y, Chiu S
PLoS One. 2012; 7(5):e36659.
PMID: 22606280
PMC: 3350502.
DOI: 10.1371/journal.pone.0036659.
Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems.
Maillard J
Ther Clin Risk Manag. 2008; 1(4):307-20.
PMID: 18360573
PMC: 1661639.
Biology of Pseudomonas stutzeri.
Lalucat J, Bennasar A, Bosch R, Garcia-Valdes E, Palleroni N
Microbiol Mol Biol Rev. 2006; 70(2):510-47.
PMID: 16760312
PMC: 1489536.
DOI: 10.1128/MMBR.00047-05.